Isoniazid News and Research

RSS
Rifampin provides new way to treat latent tuberculosis

Rifampin provides new way to treat latent tuberculosis

Increasing transmission of drug resistant tuberculosis in the UK

Increasing transmission of drug resistant tuberculosis in the UK

Hard to treat TB case diagnosed in Britain

Hard to treat TB case diagnosed in Britain

Twist in the battle against TB

Twist in the battle against TB

Rifapentine is back for tuberculosis

Rifapentine is back for tuberculosis

TB appears again in the U.S.

TB appears again in the U.S.

TB vaccine can be a killer for babies with HIV

TB vaccine can be a killer for babies with HIV

Moxifloxacin drug combo speeds up treatment of tuberculosis

Moxifloxacin drug combo speeds up treatment of tuberculosis

WHO ready to tackle drug resistant TB

WHO ready to tackle drug resistant TB

New plan to contain extensively drug-resistant TB (XDR-TB)

New plan to contain extensively drug-resistant TB (XDR-TB)

Trans-Atlantic air traveler in quarantine with dangerous TB

Trans-Atlantic air traveler in quarantine with dangerous TB

Extremely drug resistant TB a serious problem in India

Extremely drug resistant TB a serious problem in India

Patient adherence an essential factor for successful tuberculosis treatment

Patient adherence an essential factor for successful tuberculosis treatment

WHO adds four anti-tuberculosis medicines to its list of prequalified medicines

WHO adds four anti-tuberculosis medicines to its list of prequalified medicines

U.S. tuberculosis rates all-time low in 2006

U.S. tuberculosis rates all-time low in 2006

Majority of South Africans with HIV have drug resistant TB

Majority of South Africans with HIV have drug resistant TB

XDR-TB in South Africa

XDR-TB in South Africa

Sequella receives FDA fast track status for pulmonary tuberculosis drug

Sequella receives FDA fast track status for pulmonary tuberculosis drug

TB drug isoniazid could reduce AIDS-related illnesses among children

TB drug isoniazid could reduce AIDS-related illnesses among children

Measures to combat XDR-TB worldwide

Measures to combat XDR-TB worldwide

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.